BNP Paribas Asset Management’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
SCM
DM
BNP Paribas Asset Management's INSP Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its Inspire Medical Systems (INSP) stake by 25% in Q2 2026, selling an estimated $6.45K and leaving 407 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2078.
BNP Paribas Asset Management first reported a position in INSP in Q2 2025 and has held it in 5 quarters since. The position peaked at $37K in Q2 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- BNP Paribas Asset Management held 407 shares of Inspire Medical Systems worth $18.2K as of Q2 2026.
- BNP Paribas Asset Management sold 136 Inspire Medical Systems shares in Q2 2026, an estimated $6.45K.
- Inspire Medical Systems made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2078 holding.
- BNP Paribas Asset Management first reported a position in Inspire Medical Systems in Q2 2025 and has held it in 5 quarters since.
- BNP Paribas Asset Management's Inspire Medical Systems position peaked at $37K in Q2 2025.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.